A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson’s disease patients - Stocchi, F; Borgohain, R; Onofrj, M; Schapira, AHV; Bhatt, M; Lucini, V (Mov Disord, 2012)